Clinical Trial Update: The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing how limiting measles vaccination to children under 12 months affected overall mortality in a national program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Drugs mentioned

• Measles vaccine (Measles vaccine)

Snippet

Sponsor: Bandim Health Project | Conditions: Mortality, Vaccines | Phase 4 | Status: COMPLETED